China Mammography Market Size, Share, By Product Type (Analog Mammography Systems, Digital Mammography Systems, Breast Tomosynthesis Systems), By Technology (2D Mammography, 3D Mammography), By Application (Breast Cancer Screening, Diagnostic Imaging), By End Use (Hospitals, Diagnostic Centers, Specialty Clinics), By Age Group (Below 40 Years, 40-49 Years, 50 Years & Above), China Mammography Market Insights, Industry Trend, Forecasts to 2035.
Industry: Healthcare
China Mammography Market Insights Forecasts to 2035
- China Mammography Market Size 2024: USD 130.7 Mn
- China Mammography Market Size 2035: USD 450.5 Mn
- China Mammography Market CAGR 2024: 11.91%
- China Mammography Market Segments: Product Type, Technology, Application, End Use, and Age Group.
Get more details on this report -
The China mammography market consists of advanced imaging systems and technologies used for the early detection and diagnosis of breast cancer among women. The breast cancer screening process uses mammography, which employs low-dose X-ray imaging systems to identify abnormal tissue changes that enable healthcare professionals to detect cancer at early stages. Hospitals, diagnostic centres and specialized oncology clinics use these systems for their medical needs. The market is progressing because digital imaging technology has achieved advancements, 3D mammography systems have become available, and diagnostic tools with artificial intelligence support have been developed, while healthcare systems in China have received better infrastructure.
Presently, the government funds national cancer screening programs and healthcare modernization policies, which represent the main sources of support for the mammography sector. Regulatory authorities support breast cancer awareness campaigns, which help to detect breast cancer in its early stages, through their backing of new diagnostic technology adoption, which forms part of major field advancements. Future developments depend on three main factors, which include increasing healthcare investments, increasing breast cancer screening awareness, and expanding imaging technology capabilities.
Market Dynamics of the China Mammography Market:
The driving forces behind this market include the increasing incidence of breast cancer, better knowledge of early detection methods, and the expansion of Chinese healthcare facilities. The implementation of national cancer screening programs together with healthcare reform initiatives enables greater utilization of mammography equipment. The development of digital mammography, 3D tomosynthesis, and artificial intelligence diagnostic systems enables better diagnostic accuracy and improved patient results.
The challenges faced by the market include the expense of equipment, the lack of advanced screening technologies in rural areas, and the requirement for radiologists to examine mammography scans. People who have radiation exposure concerns together with those who do not know about screening programs may decrease their screening rates. Hospital information systems face operational difficulties because of technical problems that arise during system maintenance and system integration.
The future prospects for China's mammography market are positive, and these include national breast cancer screening program expansion, 3D mammography system adoption, artificial intelligence integration into diagnostic imaging, and mobile screening unit development. This is attributed to increasing healthcare investments and better diagnostic technologies together with government healthcare policies, among others.
China Mammography Market Report Coverage
| Report Coverage | Details |
|---|---|
| Base Year: | 2024 |
| Market Size in 2024: | USD 130.7 Million |
| Forecast Period: | 2025-2035 |
| Forecast Period CAGR 2025-2035 : | 11.91% |
| 2035 Value Projection: | USD 450.5 Million |
| Historical Data for: | 2020-2023 |
| No. of Pages: | 210 |
| Tables, Charts & Figures: | 87 |
| Segments covered: | By Product Type, By Technology, By Application, By End Use, By Age Group |
| Companies covered:: | Hologic, Inc., GE HealthCare Technologies Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Koninklijke Philips N.V., Canon Medical Systems Corporation, Carestream Health, Inc., Metaltronica S.p.A., and Shenzhen Anke High-tech Co., Ltd. |
| Pitfalls & Challenges: | COVID-19 Impact, Challenges, Future, Growth, & Analysis |
Get more details on this report -
Market Segmentation
The China mammography market share is classified into product type, technology, application, end use, and age group.
By Product Type:
The China mammography market is divided by product type into analog mammography systems, digital mammography systems, and breast tomosynthesis systems. Among these, the digital mammography systems segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The digital mammography systems are leading in the market because these systems have better image quality, processing speed, and diagnostic accuracy. The healthcare facilities are opting for the digital mammography systems because these systems are efficient in sharing medical images with the help of the latest hospital information systems.
By Technology:
The China mammography market is divided by technology into 2D mammography and 3D mammography. Among these, the 3D mammography segment dominated in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Three-dimensional mammography, which people commonly call breast tomosynthesis, creates multiple detailed breast tissue images that help radiologists find abnormalities more accurately. The technology enables healthcare facilities throughout China to adopt breast cancer detection methods that lower false positive rates while enhancing early disease identification.
By Application:
The China mammography market is divided by breast cancer screening and diagnostic imaging. Among these, breast cancer screening dominated in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Screening applications function as essential tools to identify breast cancer in its initial stages among women who do not show any symptoms. The demand for mammography screening services in China has risen because of three factors, which include increased public awareness through educational programs, national screening programs and healthcare campaigns that promote early detection of diseases.
By End Use:
The China mammography market is divided by end use into hospitals, diagnostic centers, and speciality clinics. Among these, the hospitals segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Hospitals remain the primary facilities for mammography procedures due to the availability of advanced diagnostic equipment, skilled radiologists, and integrated healthcare services. The expansion of hospital infrastructure and increasing investments in medical imaging technologies are supporting the growth of mammography services within hospital settings.
By Age Group:
The China mammography market is divided by age group into below 40 years, 40–49 years, and 50 years & above. Among these, the 50 years & above segments dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Women aged 50 years and above represent the largest target group for mammography screening due to the higher risk of breast cancer associated with aging. Healthcare authorities and medical professionals strongly recommend routine screening for women in this age group to ensure early detection and timely treatment.
Competitive Analysis:
The report offers the appropriate analysis of the key organisations/companies involved within the China mammography market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Key Companies in China Mammography Market:
- Hologic, Inc.
- GE HealthCare Technologies Inc.
- Siemens Healthineers AG
- Fujifilm Holdings Corporation
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Carestream Health, Inc.
- Metaltronica S.p.A.
- Shenzhen Anke High-tech Co., Ltd.
Recent Developments in China Mammography Market:
In December 2025, Hologic, Inc. reported new clinical findings supporting its Genius AI Detection Solution, an artificial intelligence-enabled mammography technology designed to assist radiologists in detecting breast cancer during screening exams. The development highlights the increasing integration of AI-based tools in mammography imaging to improve diagnostic accuracy and support early detection programs in healthcare facilities worldwide.
In November 2025, Siemens Healthiness AG introduced upgraded capabilities for its MAMMOMAT B.brilliant mammography platform, enhancing contrast-enhanced mammography imaging and biopsy guidance technology. The product advancement improves high-resolution breast imaging performance and supports healthcare providers in improving breast cancer detection and diagnosis.
In September 2025, Hologic, Inc. presented new research on its AI-powered mammography screening technology at the European Society of Breast Imaging conference, demonstrating the ability of artificial intelligence to assist radiologists in identifying aggressive breast cancer cases during screening programs.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the China, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the China mammography market based on the below-mentioned segments:
China Mammography Market, By Product Type
- Analog Mammography Systems
- Digital Mammography Systems
- Breast Tomosynthesis Systems
China Mammography Market, By Technology
- 2D Mammography
- 3D Mammography
China Mammography Market, By Application
- Breast Cancer Screening
- Diagnostic Imaging
China Mammography Market, By End Use
- Hospitals
- Diagnostic Centers
- Specialty Clinics
China Mammography Market, By Age Group
- Below 40 Years
- 40–49 Years
- 50 Years & Above
Frequently Asked Questions (FAQ)
-
What is the size of the China mammography market in 2024?The China mammography market was valued at USD 130.7 million in 2024. The market includes advanced imaging systems used for breast cancer screening and diagnosis across hospitals, diagnostic centers, and speciality clinics in China.
-
What is the projected size of the China mammography market by 2035?The China mammography market is projected to reach USD 450.5 million by 2035, supported by increasing awareness of breast cancer screening, growing healthcare infrastructure, and the adoption of advanced imaging technologies.
-
What is the CAGR of the China mammography market during the forecast period?The China mammography market is expected to grow at a compound annual growth rate (CAGR) of 11.91% from 2025 to 2035, driven by technological advancements in digital imaging, increasing screening programs, and rising healthcare investments.
-
What factors are driving the growth of the China mammography market?The market growth is driven by increasing breast cancer incidence, improved awareness of early detection methods, expanding healthcare infrastructure, and government-supported cancer screening programs. Technological innovations such as digital mammography, 3D breast tomosynthesis, and artificial intelligence-assisted imaging also support market expansion.
-
What are the major challenges in the China mammography market?Major challenges include high equipment costs, limited access to advanced screening technologies in rural areas, and the need for trained radiologists to interpret mammography scans. Concerns related to radiation exposure and limited awareness in certain regions can also affect screening participation.
-
Which product type dominates the China mammography market?Among product types, digital mammography systems dominate the market due to their higher image quality, faster processing speed, and improved diagnostic accuracy. These systems also enable efficient storage and sharing of medical images through modern hospital information systems.
-
Which technology segment holds the largest share in the China mammography market?The 3D mammography segment holds the largest share because it produces detailed layered images of breast tissue, enabling radiologists to detect abnormalities more accurately and reduce false positive results.
-
What are the major applications of mammography in China?Mammography is mainly used for breast cancer screening and diagnostic imaging. Among these, breast cancer screening is the dominant application because it helps detect cancer at an early stage among women without visible symptoms.
-
Which end-use sector dominates the China mammography market?The hospitals segment dominates the market due to the availability of advanced imaging equipment, experienced radiologists, and integrated healthcare services required for breast cancer screening and diagnosis.
-
Who are the major companies operating in the China mammography market?Key companies operating in the China mammography market include Hologic, Inc., GE HealthCare Technologies Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Koninklijke Philips N.V., Canon Medical Systems Corporation, Carestream Health, Inc., Metaltronica S.p.A., and Shenzhen Anke High-tech Co., Ltd. These companies provide advanced mammography imaging technologies and diagnostic solutions.
Need help to buy this report?